Elkjær, Amanda Lynggaard http://orcid.org/0000-0002-6802-432X
Næser, Esben Uggerby http://orcid.org/0000-0001-8185-9666
Aaen, Katja Thorup http://orcid.org/0000-0001-9096-2489
Hovgaard, Henrik Lynge http://orcid.org/0000-0001-6447-1790
Juhl-Olsen, Peter http://orcid.org/0000-0003-1951-9091
Bendstrup, Elisabeth http://orcid.org/0000-0002-4238-6963
Søndergaard, Klaus http://orcid.org/0000-0002-8357-2789
Funding for this research was provided by:
Gigtforeningen (R185-A6640, R192-A6758)
Aarhus University Hospital
Article History
Received: 18 November 2023
Accepted: 30 December 2023
First Online: 10 February 2024
Declarations
:
: E Næser reports lecture fees from Boehringer Ingelheim. HL Hovgaard reports unrestricted research grant from Aarhus University and the Novo Nordisk Foundation; travel support from Aarhus University. K Søndergaard reports unrestricted research grants from Boehringer Ingelheim and the Danish Rheumatism Association. K Søndergaard also reports consultant and lecturing fees from Boehringer Ingelheim; travel fees from UCB. E Bendstrup reports lecture fees from Boehringer Ingelheim, Daiichi-Sankyo, and Astra Zeneca. E Bendstrup also reports; travel and congress, and consulting fees from Boehringer Ingelheim. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
: The research project was approved by the Central Denmark Region Committees on Health Research Ethics (1-10-72-203-20) and listed in the Central Denmark Region register of internal research projects (1-16-02-270-20). ClinicalTrials.gov identifier: NCT04650659.
: Informed consent was obtained from all individual participants included in the study.